Professor Ronit Satchi-Fainaro‘s lab at the Faculty of Medical and Health Sciences at Tel Aviv University (TAU) collaborated with Professor Helena Florindo’s lab at the University of Lisbon to produce a novel nano-vaccine for COVID-19. The nano-vaccine, a 200-nanometer particle, trains the immune system against all common COVID-19 variants just as effectively as existing vaccines…. Read More
A new Tel Aviv University (TAU) study rejects assertions that the origin of the COVID-19 outbreak was in bats. According to the study, bats have a highly effective immune system that enables them to deal relatively easily with viruses considered lethal for other mammals. The study was led by Dr. Maya Weinberg from the laboratory… Read More
A team of researchers from Tel Aviv University (TAU) has demonstrated that antibodies isolated from the immune system of recovered COVID-19 patients are effective in neutralizing all known strains of the virus, including the Delta and the Omicron variants. According to the researchers, this discovery may eliminate the need for repeated booster vaccinations and strengthen… Read More
A new study from Tel Aviv University (TAU) found a promising treatment for long-term COVID-19 symptoms based on advanced Hyperbaric Oxygen Therapy (HBOT). The study is the first randomized controlled trial to demonstrate a real solution for long COVID. Patients exposed to an intensive protocol of HBOT treatments showed significant improvement compared to a control… Read More
A new study by Tel Aviv University (TAU) and Ben Gurion University of the Negev, in collaboration with the Israeli Ministry of Health, has found that a fourth dose of the existing COVID-19 vaccine is effective in protecting the elderly population in long-term care facilities from the Omicron variant. The research was based on a… Read More
A new Tel Aviv University (TAU) study reveals that many SARS-CoV-2 variants are likely formed in chronic COVID-19 patients who suffer from immunosuppression. The researchers suggest that a weakened antibody response, particular in the lower airways of these chronic patients, may prevent full recovery from the virus and drive the virus to mutate many times… Read More
A new study from Tel Aviv University (TAU) enables vaccine developers to determine vaccine safety via smart wearable sensors that measure objective physiological parameters. According to the researchers, most clinical trials testing the safety of new vaccines. including COVID-19 vaccines, rely on participants’ subjective reports, which can lead to biased results. In contrast, objective physiological… Read More
Experts from Tel Aviv University (TAU) have shown that a new combination of common dietary supplements can provide protection against the COVID-19 virus as well as several common winter illnesses. The study was led by Professor Ehud Gazit, Professor Eran Bacharach, and Professor Daniel Segal of the Shmunis School of Biomedicine and Cancer Research at… Read More